CLINICAL TRIALS PROFILE FOR OLEPTRO
✉ Email this page to a colleague
All Clinical Trials for OLEPTRO
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00253890 ↗ | Insomnia and Drug Relapse Risk | Completed | National Institute on Drug Abuse (NIDA) | Phase 3 | 2005-10-01 | The purposes of this study are: 1. to evaluate the relationship between subjective complaints of sleep and objective measures of sleep quality, as measured through polysomnography, and 2. to evaluate the efficacy of trazodone, as compared to placebo, in individuals early in methadone maintenance. |
| NCT00253890 ↗ | Insomnia and Drug Relapse Risk | Completed | Butler Hospital | Phase 3 | 2005-10-01 | The purposes of this study are: 1. to evaluate the relationship between subjective complaints of sleep and objective measures of sleep quality, as measured through polysomnography, and 2. to evaluate the efficacy of trazodone, as compared to placebo, in individuals early in methadone maintenance. |
| NCT00775203 ↗ | A Randomized, Double-blind, Two-arm Study Comparing the Efficacy and Safety of Trazodone Contramid® OAD and Placebo in the Treatment of Unipolar Major Depressive Disorder. | Completed | Labopharm Inc. | Phase 3 | 2007-06-01 | The purpose of this study was to demonstrate efficacy, safety and clinical benefit of Trazodone Contramid® OAD (Once A Day) in the treatment of Unipolar Major Depressive Disorder (MDD). |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for OLEPTRO
Condition Name
Clinical Trial Locations for OLEPTRO
Trials by Country
Clinical Trial Progress for OLEPTRO
Clinical Trial Phase
Clinical Trial Sponsors for OLEPTRO
Sponsor Name
